Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minoxidil Sublingual Tablet in Male Androgenetic Alopecia
NCT06924632Phase 3Completed
- Sponsor
- Samson Clinical
- Start
- Jul 2025
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of minoxidil in androgenetic alopecia (AGA), sponsored by Samson Clinical. Started Jul 2025; status: completed.
02
Drugs
minoxidil
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT06924632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06924632.